Rights and permissions
About this article
Cite this article
Lumiracoxib receives expanded approval for OA in Canada. Inpharma Wkly. 1599, 19 (2007). https://doi.org/10.2165/00128413-200715990-00046
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200715990-00046